logo
Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds

Value-Based Care Simplifies Healthcare for Patients and Clinicians, New Report Finds

Value-based care results in patients spending more time with their primary care clinician, less time in the hospital, and more frequent preventive care, based on research released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its annual Value-Based Care Report.
Over a decade of Humana's research shows value-based care improves patient outcomes. (Photo: Humana)
The report's data shows that Medicare Advantage (MA) patients receiving care under value-based arrangements saw fewer emergency department visits, fewer inpatient hospitalizations, and received more preventive care screenings.
Clinicians under the traditional fee-for-service model are reimbursed based on the volume of patients and services provided, with no incentive to reduce costly or low-value interventions. The value-based model emphasizes preventive care and incentivizes health outcomes.
'Coordinated care that delivers the right care at the right time must become the standard,' said Dr. Kate Goodrich, Chief Medical Officer at Humana. 'Our report paints a clear picture: value-based practices deliver better patient experiences and health outcomes. Patients spend more time with their primary care clinician, which means more preventive care and better management of chronic diseases, like diabetes and high blood pressure. Seniors in value-based care models receive the care they deserve with a clinician who holistically understands their care needs. At Humana, we are committed to advancing value-based care as the best model for improving health outcomes and the healthcare experience for seniors everywhere.'
A Smarter Healthcare Model
The need to accelerate value-based adoption is more imperative than ever. Clinicians are increasingly experiencing high levels of burnout, while patients struggle with a fragmented healthcare system characterized by disjointed appointments, and lack of coordinated care.
Value-based agreements range from financial rewards to full-risk reimbursement models allowing practices to choose what works best for them. Clinicians are incentivized to prioritize high-value, preventive care to keep patients healthy longer. As practices mature in value-based arrangements, care coordination becomes more effective across care teams, which results in more high value services and fewer unnecessary or duplicative services. With the alignment of financial incentives to delivery of high-quality care, care gaps close and patient engagement increases under an integrated clinical team.
Based on more than a decade of Humana's data, value-based care advances:
Patients spend more time with their primary care clinician and have fewer emergency department and hospital visits, in turn reducing costly, low-value care.
A clinical team-based approach to care coordination - after a hospital stay, between primary care visits, or when beginning a new medication.
A sustainable healthcare system, where patients, clinicians, and payers benefit from the financial stability and better outcomes of value-driven models.
Technology integrations allow for real-time, actionable data at the fingertips of clinicians to eliminate gaps in care.
Key Findings from the report:
Regular primary care appointments mean better prevention and healthcare maintenance. In 2023, value-based care members saw their primary care clinicians 10% more than non-value-based care patients.
VBC Medicare Advantage patients report 90 out of 100 satisfaction with their healthcare provider, per Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey data.
Less time spent in the hospital. VBC Medicare Advantage patients saw 32.1% fewer inpatient admissions in 2023 versus those enrolled in Original Medicare.
Humana Medicare Advantage members treated by value-based clinicians experienced 11.6% fewer ER visits and 7.2% fewer admissions than those not in a value-based arrangement.
Humana Medicare Advantage members receive more preventive screenings than those under non-value-based practices across these measures: annual wellness exam, colorectal screening, diabetes eye exam, and mammogram.
Value-based care allows for better chronic disease management. Humana Medicare Advantage members were more likely to receive diabetes care eye exam screenings and to meet blood sugar control measures versus members not in a value-based care arrangement.
Senior-focused primary care organizations (PCOs) combine a VBC model with a care delivery approach tailored for seniors. Black patients visited their senior-focused primary care clinician 39% more and low-income beneficiaries had 21% more visits versus Original Medicare.
Senior-focused primary care patients had 17% more primary care visits, 6% fewer hospitalizations and 11% fewer emergency department (ED) visits.
Value-based arrangements allow for investments in benefits members value most at an affordable price. In 2023, Humana Medicare Advantage value-based arrangements saved 25.8%, in medical costs compared to Original Medicare. Humana invests these savings directly into more member benefits, such as lower premiums, home care, prescription delivery and healthy food cards.
Beyond Primary Care
The new report also spotlights how value-based arrangements in specialty practices positively impact patient outcomes. Humana MA patients aligned to value-based nephrology programs experienced 5% fewer unnecessary hospitalizations versus fee-for-service clinicians.
'We must unite to address clinicians' pain points, creating a system where every stakeholder can prioritize health first,' said George Renaudin, Humana's Insurance President. 'Over a decade of our experience and research shows that providers navigating the shift to value achieve greater success with proactive support, an operational roadmap and actionable data. The path forward is clear: the value-based model is the future – we have seen it in action, and it's the key to sustainable, patient-centered care.'
Humana offers a practical how-to-guide for successful value-driven operations. Real-time, integrated data systems are a first step for any practice in moving toward value. For a sustainable healthcare system, the value-based care model is a necessity for patients and clinicians.
Read Humana's Value-Based Care Report in full here.
About Humana
Humana Inc. (NYSE: HUM) is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Cait Crenshaw Whatley
SOURCE: Humana Inc.
Copyright Business Wire 2025.
PUB: 02/05/2025 08:45 AM/DISC: 02/05/2025 08:47 AM
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems
Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems

Business Wire

time4 hours ago

  • Business Wire

Tim Hingtgen to Retire as Chief Executive Officer of Community Health Systems

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the 'Company') ('CHS') (NYSE: CYH) and its Board of Directors announced today that Tim Hingtgen will retire from his position as chief executive officer and as a member of the Board, effective September 30, 2025. It is anticipated that Hingtgen will enter into a consulting agreement in which he will continue to advise the Company's management team on issues related to healthcare operations and other Company matters. Kevin Hammons, who currently serves as president and chief financial officer, will assume the role of interim chief executive officer upon Hingtgen's retirement, and Jason K. Johnson, who currently serves as senior vice president and chief accounting officer, will become interim chief financial officer. During his nearly 18-year tenure at CHS, Hingtgen has held a variety of key operational leadership roles. He served as president and chief operating officer from September 2016 to December 2020 and became CEO in January 2021. Commenting about his decision to retire now, Hingtgen said, 'It has been a great privilege to serve as the chief executive officer of CHS and incredibly gratifying to lead an organization that is devoted to helping people get well and live healthier. I am so proud of the accomplishments we've made and I look forward to watching the CHS team continue to achieve their goals. My decision to retire this year is for personal reasons, including a desire to spend more time with my family and to pursue a few dreams I have for my life. This is the right time for me to do that. CHS is a great organization, and I'm confident that it will continue to advance in every possible way under the capable leadership of Kevin Hammons and the many other people who are leading CHS forward.' Kevin Hammons has been an integral member of the CHS finance team for more than 28 years. He was appointed chief financial officer in January 2020. Hammons is deeply involved in all of the Company's strategic, operational, and financial initiatives and a huge advocate for caregivers and patients. In addition to overseeing financial management and reporting responsibilities, treasury, capital market transactions, investor relations, and other duties of the CFO, Hammons is a driving force behind CHS' portfolio optimization project and he participates in the oversight of corporate teams supporting CHS-affiliated health systems. Hammons said, 'I am honored to assume the role of interim chief executive officer and look forward to contributing even more to the progress well underway at CHS. We remain committed to enhancing patient care and outcomes, serving as good partners for our clinicians and caregivers, continuously improving the Company's performance, and providing value for all of our stakeholders. Tim has been an exceptional CEO whom we all admire very much. I'm grateful that he will leave us very well positioned for further success upon his retirement.' Jason K. Johnson joined CHS in 2012 as vice president and assistant corporate controller. In 2018, he was promoted to corporate controller and, in 2019, he was appointed chief accounting officer. Johnson serves as a member of the Company's executive team. Hammons added, 'I've worked with Jason for more than a decade and appreciate his willingness to step into this role on an interim basis. Jason is highly regarded by his peers and possesses financial expertise, deep company knowledge, and a confident approach to his work. He's exactly the right person to serve as interim CFO.' Commenting about the leadership changes, Wayne T. Smith, chairman of the Community Health Systems, Inc. Board of Directors, said, 'The Board of Directors is confident that Tim, Kevin, Jason and other Company executives will work closely together to ensure a seamless transition of leadership. Kevin and Jason will excel in their interim roles and in supporting our most important responsibility of providing quality care for patients. I also want to express my personal appreciation for the strong leadership Tim has provided for the Company. He is truly one of the most committed, caring, energetic, and results-oriented executives that I've had the privilege to know and to work with. The Board and I wish him great happiness and fulfillment as he pursues his life's goals.' About Community Health Systems, Inc. Community Health Systems, Inc. is one of the nation's largest healthcare companies. The Company's affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. The Company's subsidiaries own or lease 70 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. The Company's headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol 'CYH.' More information about the Company can be found on its website at Forward-Looking Statements This press release may include information that could constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risk and uncertainties. The Company undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise, except as otherwise required by law.

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'
Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Yahoo

time9 hours ago

  • Yahoo

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company's recent earnings report results, Cramer said: 'Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we've long owned for the Charitable Trust… I'd say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook. wavebreakmedia/ Abbott (NYSE:ABT) is a healthcare company engaged in the research, development, manufacture, and marketing of a wide range of medical products. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Jim Cramer on Eli Lilly: 'It Needs Breakthroughs in New Areas'
Jim Cramer on Eli Lilly: 'It Needs Breakthroughs in New Areas'

Yahoo

time9 hours ago

  • Yahoo

Jim Cramer on Eli Lilly: 'It Needs Breakthroughs in New Areas'

Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, he did express uncertainty about its future as he stated: 'What I'm thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that there might be a short-term peak in the use of these drugs (GLP-1s). The Achilles heel of these drugs is that they're too effective. At some point, you lose enough weight, and you might think you can stop taking them… Whatever the case, if Eli Lilly is going to break out from this level, it needs breakthroughs in new areas, heart, brain, that it just doesn't have right now, or there has to be some new data that shows something else positive that the GLP-1 drugs can do. Photo by Myriam Zilles on Unsplash Eli Lilly (NYSE:LLY) is engaged in the research, development, and sale of pharmaceutical products, including therapies for diabetes, cancer, autoimmune disorders, pain, and migraines. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store